Treace Medical (TMCI) Concepts announced that its Board of Directors has appointed John Treace, CEO and Founder of Treace, as the Chairman of the Board to be effective immediately following the 2025 annual meeting of stockholders. John Treace will succeed James Treace, who notified the Board that he will retire from the Board when his current term as a director ends at the 2025 Annual Meeting of Stockholders, which is expected to occur on May 20, 2025. John Treace will continue to serve as CEO and will assume the role of Chairman of the Board immediately following the 2025 Annual Meeting of Stockholders. Richard Mott will continue to serve as the lead independent director.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMCI: